Lyra Therapeutics Ownership | Who Owns Lyra Therapeutics?
Lyra Therapeutics Ownership Summary
Lyra Therapeutics is owned by 41.07% institutional investors, 0.60% insiders, and 58.33% retail investors. Perceptive advisors is the largest institutional shareholder, holding 19.49% of LYRA shares. iShares Russell 2000 ETF is the top mutual fund, with 3.59% of its assets in Lyra Therapeutics shares.
LYRA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Lyra Therapeutics | 41.07% | 0.60% | 58.33% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Perceptive advisors | 12.76M | 19.49% | $2.63M |
| Blackrock funding, inc. /de | 3.11M | 4.75% | $641.86K |
| Blackrock | 2.83M | 4.42% | $783.05K |
| Samsara biocapital | 1.97M | 3.00% | $405.72K |
| Vanguard group | 1.79M | 2.73% | $368.21K |
| Ikarian capital | 1.06M | 1.62% | $218.40K |
| Geode capital management | 885.97K | 1.35% | $182.89K |
| Morgan stanley | 811.75K | 1.27% | $224.61K |
| Goldman sachs group | 555.51K | 0.85% | $114.66K |
| Adar1 capital management | 533.20K | 0.81% | $110.05K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Perceptive advisors | 12.76M | 0.07% | $2.63M |
| Samsara biocapital | 1.97M | 0.06% | $405.72K |
| Ikarian capital | 1.06M | 0.03% | $218.40K |
| Adar1 capital management | 533.20K | 0.02% | $110.05K |
| Abel hall | 17.65K | 0.00% | $3.64K |
| Boothbay fund management | 233.99K | 0.00% | $48.30K |
| Caption management | 246.60K | 0.00% | $68.23K |
| Virtu financial | 42.07K | 0.00% | $9.00K |
| Tower research capital llc (trc) | 39.78K | 0.00% | $8.20K |
| Two sigma advisers, lp | 385.50K | 0.00% | $79.57K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 2.83M | - | 2.68M |
| Morgan stanley | 811.75K | - | 747.35K |
| Adar1 capital management | 533.20K | 0.02% | 533.20K |
| Ubs group | 424.96K | - | 400.05K |
| Qube research | 342.16K | 0.00% | 342.16K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Nantahala capital management | - | - | -2.82M |
| Point72 asset management | - | - | -2.74M |
| Vr adviser | - | - | -2.58M |
| Pura vida investments | - | - | -1.41M |
| Rosalind advisors | - | - | -1.03M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Adar1 capital management | 533.20K | 0.02% | 533.20K | $110.05K |
| Qube research | 342.16K | 0.00% | 342.16K | $70.62K |
| Caption management | 246.60K | 0.00% | 246.60K | $68.23K |
| Bnp paribas arbitrage, snc | 244.92K | - | 244.92K | $50.55K |
| Abel hall | 17.65K | 0.00% | 17.65K | $3.64K |
Sold Out
| Holder | Change |
|---|---|
| Farther finance advisors | -38.00 |
| Northwestern mutual wealth management | -70.00 |
| Capital performance advisors llp | -533.00 |
| Macquarie group | -1.38K |
| Geneos wealth management | -3.54K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 54 | -12.90% | 26,885,924 | -17.35% | 41 | 1.66% | 28 | -12.50% | 12 | -14.29% |
| Sep 30, 2024 | 61 | 15.09% | 32,528,511 | -0.62% | 49 | 1.90% | 31 | 10.71% | 14 | 7.69% |
| Jun 30, 2024 | 53 | -35.37% | 32,730,433 | -28.15% | 51 | 0.61% | 28 | -47.17% | 13 | -7.14% |
| Mar 31, 2024 | 82 | 30.16% | 45,556,221 | 7.55% | 91 | 1.65% | 53 | 17.78% | 14 | 366.67% |
| Dec 31, 2023 | 63 | 34.04% | 42,358,020 | 32.66% | 74 | 1.39% | 45 | 80.00% | 3 | -50.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Russell 2000 ETF | 2.37M | 3.59% | -20.52K |
| Vanguard US Total Market Shares ETF | 992.54K | 1.51% | 2.00 |
| Vanguard Total Stock Mkt Idx Inv | 992.54K | 1.51% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 455.83K | 0.69% | - |
| iShares Russell 2000 Growth ETF | 406.93K | 0.62% | -1.94K |
| Fidelity Small Cap Index | 317.10K | 0.48% | -5.94K |
| Fidelity Extended Market Index | 224.53K | 0.34% | -1.43K |
| Vanguard Russell 2000 ETF | 221.55K | 0.34% | 5.20K |
| Russell 3000 Screened Index Composite | 186.70K | 0.29% | 186.70K |
| Spartan Total Market Index Pool E | 140.13K | 0.21% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 10, 2023 | Waksal Harlan | Executive Chair | Buy | $74.09K |
| May 31, 2023 | NBVM GP, LLC | - | Buy | $981.37K |
| May 31, 2023 | NBVM GP, LLC | - | Buy | $481.01K |
| May 31, 2023 | NBVM GP, LLC | - | Buy | $1.61M |
| May 31, 2023 | NBVM GP, LLC | - | Buy | $2.92M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q4 | 1 | - |
LYRA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools